<DOC>
	<DOCNO>NCT00936247</DOCNO>
	<brief_summary>This investigational study investigate two different volume replacement regimes patient suffer compromised renal function .</brief_summary>
	<brief_title>Tetraspan 6 Percent ( % ) Combined With Sterofundin ISO Versus Albumin 5 Percent ( % ) Combined With Sodium Chloride ( NaCL )</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Inclusion : male female patient â‰¥ 50 year age ; patient compromise renal function , i.e . serum creatinine 1.5 mg/dl 3.0 mg/dl ; patient schedule elective intervention ; patient estimate intraoperative volume need least 1 l colloid ; provision voluntary informed consent participate study , follow full explanation nature purpose study , sign informed consent form approve Institutional Ethics Committee ( IEC ) prior evaluation Exclusion : patient ASAclass &gt; III ; patient daily urine output &lt; 1 l ; patient haemodialysis ; patient receive HES last 48 hour first infusion investigational product ; patient suffer coagulation disorder ( i.e . PTT &gt; 60 sec ) ; patient hemoglobin &lt; 9 g/dl ; patient know hypersensitivity HES , albumin excipients ; patient suffer contraindication investigational product ( i.e . hyperhydration state include pulmonary oedema , renal failure oliguria anuria , intracranial haemorrhage , hyperkalaemia , severe hypernatraemia severe hyperchloraemia , severely impaired hepatic function , congestive heart failure ) ; simultaneous participation another clinical trial ; emergency ; patient schedule brain surgery ; patient incapable give inform consent ( e.g . patient dementia , psychiatric disease suffer condition associate lack consciousness )</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>